Is this your brand? Sign in to claim ownership.
Sign in to claim this brandFUJIREBIO INC.
US
Last updated May 24, 2026
What FUJIREBIO INC. makes
The company produces in vitro diagnostic (IVD) reagents and consumables for laboratory use, including buffered sample diluents, calibrators, and chemiluminescent immunoassay kits. These products are designed for measuring biomarkers such as amyloid beta components, tau protein, cancer antigen 125 (CA125), cancer antigen 15-3 (CA15-3), and prostate-specific markers. Specific offerings include specimen diluents, calibrator sets, and immunoreaction cartridges for automated immunoassay systems. Additional items include buffered wash solutions and reagents for use in diagnostic platforms like the Lumipulse G and Beckman Coulter PK systems.
The portfolio includes devices classified as Class I, Class II, and Unclassified under regulatory frameworks, with listings in the FDA’s Unique Device Identifier (UDI) database. These products are intended for use in clinical laboratories and diagnostic settings, adhering to applicable IVD regulations. The company operates within the United States, where these devices are subject to FDA oversight.
Written from this company's registered devices by an AI model, and not verified by a human reviewer.
Frequently asked questions
What types of medical devices does FujiRebio Inc. manufacture?
FujiRebio Inc. specializes in in vitro diagnostic (IVD) reagents and consumables for laboratory use. Their products include buffered sample diluents, calibrators (such as for amyloid beta components, CA125, and CA15-3), and chemiluminescent immunoassay kits. These are designed to measure biomarkers like amyloid beta, tau protein, cancer antigens, and prostate-specific markers, often used in automated immunoassay systems like the Lumipulse G and Beckman Coulter PK platforms.
Where is FujiRebio Inc. based, and how does that affect its devices?
FujiRebio Inc. is based in the United States, where its IVD devices are subject to FDA oversight. Since the company operates within the U.S., its products must comply with FDA regulations, including classification under the agency’s framework (Class I, Class II, or Unclassified). This ensures alignment with U.S. regulatory requirements for diagnostic testing and laboratory use.
Which regulatory registries list FujiRebio Inc.’s devices?
FujiRebio Inc.’s devices are listed in the FDA’s Unique Device Identifier (UDI) database. This registry tracks authorized IVD products in the U.S., allowing healthcare providers and regulators to verify compliance and identify specific device details, such as classifications and intended uses.
How are FujiRebio Inc.’s devices classified under regulatory standards?
FujiRebio Inc.’s devices fall into three regulatory classifications: Class I (generally low-risk), Class II (moderate-risk with special controls), and Unclassified (where risk-based classification is pending or not applicable). Classification depends on factors like the device’s purpose, potential health impact, and the level of regulatory scrutiny required for safety and effectiveness in diagnostic testing.
AI-generated from registry data and not verified by a human reviewer.
Information
- Country
- US
- Address
- —
- Website
- fdi.com
- —
- —
- [email protected]
- Phone
- 610-240-3800
- PRRC Contact
- —
- EUDAMED SRN
- —
- FDA FEI Number
- —
- DUNS Number
- 710873907
Catalogue (58)
Page 1 of 2Related Companies
Authorised Representatives
No authorised representatives on record.
Importers
Not available yet.
Notified Bodies
Not available yet.
Authorities
Not available yet.
FDA Establishments (1)
Establishments registered with the FDA under this company group, matched by name.
- Fujirebio Inc. Sagamihara-shi Kanagawa · JP FEI 3002895169